HeartSciences Inc (HSCS) Actualités

Form 8-K - Current report

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Southlake, TX, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

Southlake, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

Southlake, TX, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

Form 8-K - Current report

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

Southlake, TX, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

Form 8-K - Current report

HeartSciences’ MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

Southlake, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

Form 8-K - Current report

HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio

Southlake, TX, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

Form 8-K - Current report

MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark

Southlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences...

Form 8-K - Current report